Section Arrow
CVRX.NASDAQ
- CVRx
Quotes are at least 15-min delayed:2025/01/21 05:21 EST
Last
 17.62
+0.32 (+1.85%)
Day High 
17.64 
Prev. Close
17.3 
1-M High
17.72 
Volume 
290.45K 
Bid
15
Ask
24
Day Low
17.01 
Open
17.42 
1-M Low
11.3853 
Market Cap 
419.76M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 14.87 
20-SMA 13.76 
50-SMA 14.21 
52-W High 29.23 
52-W Low 6.4 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.69/-1.26
Enterprise Value
450.14M
Balance Sheet
Book Value Per Share
2.69
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
39.30M
Operating Revenue Per Share
1.45
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
QSIQuantum-Si2.24-0.3-11.81%-- 
SENSSenseonics Holdings0.8479-0.0271-3.10%-- 
BDMDBaird Medical Investment Holdings Ltd8.85+3.43+63.28%15.32PE
BMRABiomerica0.64-0.066-9.35%-- 
MDTMedtronic plc88.08+0.92+1.06%26.61PE
Quotes are at least 15-min delayed:2025/01/21 05:21 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.